Top Markets
#1 MowCat MowCat +48.59%
#2 Bitway Bitway +26.49%
#3 Velvet Velvet +23.21%
#4 aPriori aPriori +19.57%
#5 OVERTAKE OVERTAKE +19.49%
#6 Biconomy Biconomy +15.42%
#7 Derive Derive +14.72%
#8 Zerebro Zerebro +13.81%
#9 Fake World Assets Fake World Assets +12.67%
#10 Perle Perle +11.13%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
WPD Pharmaceuticals Inc. WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc.

WBIO
Rank in Stocks #34463
WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver,... WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver, Canada, specializes in the research and advancement of therapeutic products for oncology and infectious diseases. The company's diverse drug development pipeline features multiple promising candidates: WPD101 and WPD103 are both in pre-clinical stages, targeting brain cancers, including glioblastoma and glioblastoma multiforme respectively. Also in pre-clinical development is WPD102, aimed at Uveal Melanoma. In more advanced clinical stages, Berubicin is undergoing Phase 1 trials for glioblastoma, while WP1066, also in Phase 1 clinical trials, is being investigated for central nervous system tumors, pancreatic cancer, and ocular tumors. Additionally, the pipeline includes WP1732 for pancreatic cancer and WP1220 for cutaneous T-cell lymphoma. Annamycin is currently in Phase I/II clinical trials for acute myeloid leukemia (AML) and is also being explored for lung metastasis.
Share Price
$0.04895618
Last synced: 2025-03-18
Market Cap
$5.55M
Change (1 day)
-0.04%
Change (1 year)
0.00%
Country
CA
Trade WPD Pharmaceuticals Inc. (WBIO)

Category

Healthcare
Stock price history for WPD Pharmaceuticals Inc. (WBIO)
Highest end of day price: $0.05 on 2025-03-01

Lowest end of day price: $3.04 on 2009-02-01
Stock price history of WPD Pharmaceuticals Inc. from 2009 to 2026
Annual Stock Price Performance
Year Performance
2025 -53.70%
2024 -87.50%
2023 1.29%
2022 -30.97%
2021 -78.43%
2020 -23.84%
2019 14.02%
2018 -26.68%
2017 2,566.34%
2016 2.72%
2015 17.86%
2014 -23.02%
2013 -38.03%
2012 -49.89%
2011 -37.12%
2010 -30.81%
2009 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE